Eva Font

Eva Font is Start-up and Regulatory Director at Pivotal.

Articles by Eva Font

Clinical practice across the EU and the UK is broadly comparable, supported by shared scientific guidance and similar treatment frameworks. Credit: Stock.Adobe.com/donfiore.

One Strategy, Two Jurisdictions: Unlocking Efficiency Across EU CTR and UK Regulatory Reform

June 15th 2026

How sponsors can leverage both the EU Clinical Trials Regulation and UK’s reformed framework to achieve cost efficiencies, faster timelines, and stronger regulatory positioning.

Eva Font

Articles by Eva Font

One Strategy, Two Jurisdictions: Unlocking Efficiency Across EU CTR and UK Regulatory Reform

Latest Updated Articles

Trending on Applied Clinical Trials Online

Quantifying the Net Financial Value of Deploying Risk-Based Quality Management

PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety

How the Line Between Clinical Data and Real-World Evidence Is Blurring

ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics

What Clinical Trials Can Learn from the Gig Economy About Payments